These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8053402)

  • 21. The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
    Morony S; Warmington K; Adamu S; Asuncion F; Geng Z; Grisanti M; Tan HL; Capparelli C; Starnes C; Weimann B; Dunstan CR; Kostenuik PJ
    Endocrinology; 2005 Aug; 146(8):3235-43. PubMed ID: 15845617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
    Sato K; Onuma E; Yocum RC; Ogata E
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of gallium on bone in the rat.
    Wakley GK; Garand J; Brown D; Szukalski BW; Bell NH; Turner RT
    J Bone Miner Res; 1992 Jan; 7(1):11-9. PubMed ID: 1549954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
    Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
    Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of gallium nitrate administered by prolonged infusion.
    Warrell RP; Isaacs M; Coonley CJ; Alcock NW; Bockman RS
    Cancer Treat Rep; 1985 Jun; 69(6):653-5. PubMed ID: 4016769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
    Leyland-Jones B
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating cancer-related hypercalcemia with gallium nitrate.
    Leyland-Jones B
    J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
    Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on the medical treatment of hypercalcemia of malignancy.
    Hall TG; Schaiff RA
    Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
    Torres R; de la Piedra C; Rapado A
    Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
    Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
    Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
    Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gallium nitrate revisited.
    Chitambar CR
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):1-4. PubMed ID: 12776253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of humoral hypercalcemia of malignancy on the parathyroid gland in nude mice.
    Gröne A; Rosol TJ; Baumgärtner W; Capen CC
    Vet Pathol; 1992 Jul; 29(4):343-50. PubMed ID: 1514221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro bone resorption activity produced by a hypercalcemic adenocarcinoma tumor line (CAC-8) in nude mice.
    Rosol TJ; Capen CC; Minkin C
    Calcif Tissue Int; 1986 Nov; 39(5):334-41. PubMed ID: 3102024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of gallium to treat Paget's disease of bone: a pilot study.
    Matkovic V; Apseloff G; Shepard DR; Gerber N
    Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.